1. Home
  2. GBIO vs COCH Comparison

GBIO vs COCH Comparison

Compare GBIO & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • COCH
  • Stock Information
  • Founded
  • GBIO 2016
  • COCH 1995
  • Country
  • GBIO United States
  • COCH United States
  • Employees
  • GBIO N/A
  • COCH N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • COCH Blank Checks
  • Sector
  • GBIO Health Care
  • COCH Finance
  • Exchange
  • GBIO Nasdaq
  • COCH Nasdaq
  • Market Cap
  • GBIO 29.2M
  • COCH 31.6M
  • IPO Year
  • GBIO 2020
  • COCH N/A
  • Fundamental
  • Price
  • GBIO $0.38
  • COCH $1.50
  • Analyst Decision
  • GBIO Strong Buy
  • COCH Strong Buy
  • Analyst Count
  • GBIO 4
  • COCH 2
  • Target Price
  • GBIO $7.33
  • COCH $9.25
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • COCH 20.0K
  • Earning Date
  • GBIO 08-06-2025
  • COCH 08-11-2025
  • Dividend Yield
  • GBIO N/A
  • COCH N/A
  • EPS Growth
  • GBIO N/A
  • COCH N/A
  • EPS
  • GBIO N/A
  • COCH N/A
  • Revenue
  • GBIO $24,556,000.00
  • COCH $212,000.00
  • Revenue This Year
  • GBIO N/A
  • COCH $8.04
  • Revenue Next Year
  • GBIO N/A
  • COCH $15.39
  • P/E Ratio
  • GBIO N/A
  • COCH N/A
  • Revenue Growth
  • GBIO 146.47
  • COCH N/A
  • 52 Week Low
  • GBIO $0.30
  • COCH $1.21
  • 52 Week High
  • GBIO $3.65
  • COCH $3.99
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 49.21
  • COCH 57.76
  • Support Level
  • GBIO $0.32
  • COCH $1.40
  • Resistance Level
  • GBIO $0.36
  • COCH $1.58
  • Average True Range (ATR)
  • GBIO 0.03
  • COCH 0.08
  • MACD
  • GBIO 0.00
  • COCH 0.01
  • Stochastic Oscillator
  • GBIO 64.67
  • COCH 100.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Share on Social Networks: